Join our events aimed at inspiring and guiding future leaders. Together, we can reach our full potential. Join our events aimed at inspiring and guiding future leaders.
Talk Title: Engineering Regenerative Solutions: Harnessing Naturally Derived Biomaterials for Tissue Repair
Conor Buckley is Professor In Biomedical Engineering and Director of the Trinity Centre for Biomedical Engineering at the University of Dublin, Trinity College Dublin, Ireland. Buckley is a principal investigator (PI) in both the Trinity Centre for Biomedical Engineering and Science Foundation Ireland (SFI) national centre for Advanced Materials and Bioengineering Research (AMBER) Centre at Trinity College Dublin and Honorary Professor in the Royal College of Surgeons in Ireland. His research focuses on novel biomaterials, biofabrication and cell-based strategies for tissue regeneration (www.BuckleyLab.eu).
Buckley has published over 90 international peer reviewed journal articles and over 200 conference publications. Buckley is a reviewer for 29 leading journals in the fields of Biomaterials and Tissue Engineering and serves on the International Advisory Review Board (ARB) for the Journal of Orthopaedic Research-Spine.
Buckley is also a PI on several commercial projects developing biomaterials for peripheral nerve repair and bioprinting for next generation implantable devices and tissues for orthopaedic applications. He also has experience in the commercialisation of technology including the filing and licensing of patents in relation to porous biomaterials for nerve (PCT/EP2020/083811) and cartilage tissue regeneration (EP18215447.6). In 2022, he co-founded Altach, (https://altach.health/) a campus spin-out company pioneering off-the-shelf cartilage scaffolds to regenerate damaged knee joints.
Prof. Buckley’s laboratory has been recognised through notable honours and distinctions including the Irish Research Council (IRC) New Foundations Award, Engineers Ireland Biomedical Research Medal, European Society of Biomechanics S.M. Perren Award. He is a recipient of a Science Foundation Ireland Career Development Award (CDA, 2016), a European Research Council (ERC) Consolidator award to develop personalised medicine approaches to regenerate the intervertebral disc (2019) and an ERC Proof of Concept award for injectable biomimetic self-healing tissue adhesives (2024).
Current research activities: Personalised medicine and injectable gene activated biomaterials for intervertebral disc repair; Biofabrication of electroconductive ECM nerve guidance conduits; Injectable biomimetic self-healing tissue adhesives; 3D printing of ECM derived orthopaedic models and implants; Predictive in silico metabolite modelling for cell-based therapies.
URL for web site: www.buckleylab.eu
ORCID: http://orcid.org/0000-0001-7452-4534
Google Scholar: http://scholar.google.com/citations?user=ZouPbv8AAAAJ&hl=en
LinkedIn: https://www.linkedin.com/in/conor-buckley-49683347/?originalSubdomain=ie
Research Gate: https://www.researchgate.net/profile/Conor-Buckley
Twitter: @BuckleyLabTCD
Talk title: Dermal Extracellular Matrix in Wound Healing: Applications And Therapeutic Potential
Alexandra P. Marques holds a Habilitation in Tissue Engineering, Regenerative Medicine and Stem Cells, with a specialization in Stem cells (2020), a PhD on Materials Science and Technology – Biomaterials (2004) and a BSc in Biochemistry (1997). She is Coordinating Investigator in the 3B’s Research Group, University of Minho, Portugal.
She is Associate Editor of the Skin Physiology Section of Frontiers in Physiology and is on the editorial board of several journals.
Dr. Marques is an active member of several international scientific organizations, including the European Wound Management Association (EWMA), the Tissue Engineering and Regenerative Medicine International Society (TERMIS), the European Society for Biomaterials (ESB) and the Portuguese Society for Stem Cells and Cellular Therapy (SPCE-TC). At EWMA, she has served as honorary secretary, a member of the executive and scientific committees, and presently chairs the Translational Research Committee.
Her research focuses on developing advanced in vitro models to deepen the understanding of mechanisms underlying skin conditions and diseases. By integrating stem cells and biomaterials, she has been devising innovative strategies for skin wound healing, with recent efforts centered on the role of the extracellular matrix in wound repair and skin diseases pathophysiology.
Talk Title: Biomaterial Scaffolds for the Delivery of Gene Therapeutics for Enhanced Wound Repair
Deputy Vice Chancellor for Research & Innovation
Prof. of Bioengineering & Regenerative Medicine
Head of Tissue Engineering Research Group
Deputy Director, AMBER Centre
Dept. of Anatomy & Regenerative Medicine
Royal College of Surgeons in Ireland
Prof. Fergal O’Brien is Deputy Vice Chancellor for Research & Innovation and member of the Senior Management Team in RCSI an Deputy Director of the SFI AMBER Centre. He is a leading innovator in the development of advanced biomaterials and medical devices for tissue repair publishing over 300 journal articles and graduating over 60 PhD students. He has translated a number of regenerative technologies to the clinic through spin-out company formation and licensing to industry. He is a recipient of numerous awards including a €3million Advanced Grant from the European Research Council, Fellowship of the Irish Academy for Engineering, Membership of the Royal Irish Academy and the 2023 Marshall R. Urist, MD Award from the Orthopaedic Research Society for career contribution to musculoskeletal research.
Weblinks: https://www.rcsi.com/people/profile/fjobrien
Twitter @fjobrien, @TissueEngDublin
Publications (h-index > 95)
http://scholar.google.com/citations?user=CFBzniwAAAAJ
Talk title: Wound Care and Current Treatment Approaches
Prof. Dr. Bilsev İnce is a Plastic, Reconstructive, and Aesthetic Surgery specialist with a distinguished academic and clinical career. After earning his medical degree from Gaziantep University in 2004, he completed his specialization in 2010. He served at Necmettin Erbakan University, Meram Faculty of Medicine, where he became an Associate Professor in 2016 and a Professor in 2021.
With over 140 published articles, two books on microsurgery education and rhinoplasty, and contributions to more than ten book chapters, Prof. İnce has made significant contributions to the field. He has presented at numerous national and international conferences and currently runs his private clinic in Konak, İzmir.
Talk title: Overcoming Obstacles: Key Challenges for Manufacturers of Combined ATMPs
Anke Wixmerten studied biochemistry at the University of Bielefeld, Germany, where she obtained her diploma. After five years as a team leader in industrial development, she moved to the tissue engineering laboratory of Prof Ivan Martin at the University Hospital Basel in 2008. There she established a GMP-compliant production for Tissue Engineered Products and took over the coordination of regulatory affairs for several national and international phase I and phase II studies for cartilage repair and osteoarthritis. With more than 17 years of experience in regenerative medicine and regulatory affairs, she currently heads the GMP Facility for Advanced Therapies at the University Hospital Basel (USB) in Switzerland. As Qualified person she is responsible for the GMP-compliant manufacturing of various innovative Advanced Therapy Medicinal Products (ATMPs) for clinical trials.
Talk title: Regulatory Challenges in Advanced Therapies: Navigating Innovation in Medical and Medicinal Products
PD Dr. Oliver Pullig, Assistant Professor, studied biology at the University of Mainz, Germany, and earned his PhD at the University of Erlangen, Germany. With over 14 years of experience in clinical regenerative medicine and regulatory affairs, he currently serves as Head of Regulatory Affairs and Qualified Person at the University Hospital Würzburg (UKW) in the Department of Functional Materials in Medicine. In this role, he oversees the clinical development of GMP-compliant innovative medical devices and advanced therapy medicinal products (ATMPs) for advanced therapies
Talk title: Inorganic Phosphate-based Supraparticles: New Approaches for Bone Regeneration and Drug Delivery
Dr. Sofia Dembski is Head of the Biomaterials Team at the Translational Centre for Regenerative Therapies (TLC-RT) at the Fraunhofer Institute for Silicate Research ISC in Würzburg (Germany). She is also the deputy director of the TLC-RT. With more than fifteen years of experience, Dr. Dembski specializes in the development of multifunctional (nano)particles for diagnostics and therapy, bioresorbable fibers, membrane systems and process automation. She has a strong background in project acquisition and coordination, including both public and industrial collaborations. Her proven ability to work in interdisciplinary project teams enables her to collaborate effectively with experts in biotechnology, tissue engineering and clinical research and to build strong networks within these fields.
Website: https://www.regenerative-therapien.fraunhofer.de/en.html
Linkedin: https://www.linkedin.com/in/sofia-dembski-3b070998/
ORCID: http://orcid.org/0000-0003-0427-1644
Praesentium ullamco accusamus diam quibus dam libero feugiat, doloremque lacus per natoque provident sunt habitant vivamus viverra itaque itaque dignissim frin.
This congress serves as the final conference of the HE-Twinning project titled REGENEU (Project No. 101079123), funded by the European Union.